Table 1.
N=270 | % | ||
---|---|---|---|
Gender | Male | 127 | 47 |
Female | 143 | 53 | |
Primary Cancer | Non-small cell lung cancer | 99 | 36.7 |
Breast cancer | 63 | 23.3 | |
Melanoma | 56 | 20.7 | |
Other | 52 | 19.3 | |
ECOG PS | 0 | 137 | 50.9 |
1 | 109 | 40.5 | |
2 or 3 | 23 | 8.6 | |
Missing | 1 | - | |
Active Systemic Disease | No | 140 | 52 |
Yes | 129 | 48 | |
Missing | 1 | - | |
Extracranial Metastatic Sites | No | 133 | 49.4 |
Yes | 136 | 50.6 | |
Missing | 1 | - | |
Previous WBRT | No | 185 | 68.5 |
Yes | 85 | 31.5 | |
CTX During SRS (<30 Days) | No | 213 | 79.2 |
Yes | 56 | 20.8 | |
Missing | 1 | - | |
Intact and Resected Metastases | Intact | 406 | 85.5 |
Resected | 86 | 14.5 | |
Number of Metastases Treated at First Session | 1 | 160 | 59.3 |
2 | 61 | 22.6 | |
≥3 | 49 | 18.1 | |
Median if ≥3 (Range) | 4 (3-7) | ||
Age (years) | 18-44 | 53 | 19.6 |
45-54 | 68 | 25.2 | |
55-59 | 48 | 17.8 | |
≥60 | 101 | 37.4 | |
Median (Range) | 56 (18-87) | - | |
Total Volume from First Session (cm^3) | 0-<0.3 | 45 | 17.6 |
0.3-<1.3 | 56 | 21.9 | |
1.3-<3.3 | 54 | 21.1 | |
3.3-<7.6 | 50 | 19.5 | |
≥7.6 | 51 | 19.9 | |
Mean (SD) | 4.02 (4.76) | ||
Median (Range) | 2.21 (0.032-22.3) | ||
Number of Metastases Treated at First Session | Mean (SD) | 1.78 (1.27) | |
Median (Range) | 1 (1-7) |
PS = Performance Status, WBRT = Whole Brain Radiation Therapy, CTX = Chemotherapy, SRS = Stereotactic Radiosurgery, SD = Standard Deviation